Trial of Cytisine in Adult Smokers
Public ClinicalTrials.gov record NCT03709823. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 2b Trial of Cytisine in Adult Smokers
Study identification
- NCT ID
- NCT03709823
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Achieve Life Sciences
- Industry
- Enrollment
- 254 participants
Conditions and interventions
Conditions
Interventions
- Cytisine Drug
- Placebo Comparator Drug
- Behavioral support Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 12, 2018
- Primary completion
- Apr 22, 2019
- Completion
- Apr 22, 2019
- Last update posted
- May 17, 2020
2018 – 2019
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Consortium | Tempe | Arizona | 85283 | — |
| Los Angeles Clinical Trials | Burbank | California | 91505 | — |
| Central Kentucky Research Associates, LLC | Lexington | Kentucky | 40509 | — |
| Center for Pharmaceutical Research, LLC | Kansas City | Missouri | 64114 | — |
| Rochester Clinical Research, Inc | Rochester | New York | 14609 | — |
| Coastal Carolina Research Center, Inc | Mt. Pleasant | South Carolina | 29464 | — |
| Volunteer Research Group | Knoxville | Tennessee | 37920 | — |
| FutureSearch Trails of Dallas, LP | Dallas | Texas | 57231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03709823, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 17, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03709823 live on ClinicalTrials.gov.